Status:
COMPLETED
The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
Lead Sponsor:
New York Institute of Technology
Conditions:
Blood Pressure
Eligibility:
All Genders
40-84 years
Phase:
EARLY_PHASE1
Brief Summary
The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.
Detailed Description
We will be monitoring 24 hour ambulatory BP and HR in subjects with PD on 3 separate visits. The first visit will be without an intervention to establish a baseline of 24 hour BP fluctuations. One wee...
Eligibility Criteria
Inclusion
- All subjects must have a diagnosis of PD by a licensed neurologist according to the UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria (UKPDBB).(Goetz, 2010) The UKPDBB is a 3 step diagnostic tool which defines inclusion and exclusion criteria for diagnosing PD
- between 35 and 79 years of age
- mentally able to participate in the study
Exclusion
- Pregnancy
- any person who is currently taking amino acid supplements.
- Any history of myocardial infarction, stent, or CABG
- Phenylketonurics
- Untreated hypertension
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT02259049
Start Date
October 1 2014
End Date
September 1 2015
Last Update
January 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Institute of Technology
Old Westbury, New York, United States, 11758